Eric Rougemond
About Eric Rougemond
Eric Rougemond is the Chief Executive Officer of Laboratoire Aguettant and PROMISE Advanced Proteomics, with extensive experience in the pharmaceutical industry spanning over two decades.
Work at Laboratoire Aguettant
Eric Rougemond has served as the Chief Executive Officer of Laboratoire Aguettant since 2013. Under his leadership, the company has focused on the development and production of injectable drugs and medical devices. His tenure has been marked by strategic initiatives aimed at expanding the company's market presence and enhancing operational efficiency. Laboratoire Aguettant is located in the Région de Lyon, France, where it has established itself as a key player in the pharmaceutical industry.
Previous Experience at EUSA Pharma
Before joining Laboratoire Aguettant, Eric Rougemond worked at EUSA Pharma as Vice President for France, Benelux, Nordic Countries, and Southern Europe from 2007 to 2013. In this role, he was responsible for overseeing the company's operations across multiple regions, contributing to its growth and market strategy. His experience at EUSA Pharma provided him with valuable insights into international pharmaceutical markets.
Education and Expertise
Eric Rougemond earned a Doctor of Medicine degree from the University of Medicine of Lyon, completing his studies from 1987 to 1998. He furthered his education by obtaining a Degree in Management of Pharmaceutical Industry from the University of Lyon in 1999. This combination of medical and management education has equipped him with a comprehensive understanding of both the scientific and business aspects of the pharmaceutical industry.
Role at PROMISE Advanced Proteomics
In addition to his role at Laboratoire Aguettant, Eric Rougemond has been the Chief Executive Officer of PROMISE Advanced Proteomics since 2019. His leadership at PROMISE focuses on advancing proteomics technologies and their applications in various fields, including drug development and diagnostics. This position reflects his commitment to innovation in the pharmaceutical sector.
Experience at Merck KGaA
Eric Rougemond served as Medical Director at Merck KGaA from 1999 to 2005. In this capacity, he was involved in medical affairs and strategic planning, contributing to the company's initiatives in the pharmaceutical market. His experience at Merck KGaA provided him with a solid foundation in medical and regulatory processes within the industry.